Please Wait
Applying Filters...
menu
    • menu
    TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

    Virtual Booth

    Contact Supplier

    Your reliable CDMO partner - agile, scalable, top-quality Small Molecule API & HPAPI solutions from concept to market

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    GSK

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    “Over 500 million syringes of our hyaluronic acid have been safely used worldwide”

    mic“Over 500 million syringes of our hyaluronic acid have been safely used worldwide”

    This week, SpeakPharma interviews Marie-Armelle Floc’h, Chief of Quality and Regulatory Affairs at HTL Biotechnology, a global leader in the development and the manufacturing of pharmaceutical-grade biopolymers headquartered in Javené, Brittany (France). Since 1992, HTL has pioneered the production of hyaluronic acid (HA) through proprietary biofermentation, achieving unmatched purity and consistency for applications in ophthalmology, dermatology and rheumatology. Floc’h highlights how HTL Biotechnology’s compelling portfolio of pharmaceutical-grade biopolymers is built on uncompromising quality standards. These standards have enabled the company to supply biopolymers for over 30 years without a single batch recall, firmly establishing its reputation for reliability and excellence. She also discusses the inauguration of HTL Biotechnology’s new sterile hyaluronic acid production unit — a major milestone that reinforces the company’s leadership in biopolymer manufacturing and enables the development of innovative formulations combining hyaluronic acid with thermo-sensitive active ingredients. This new capability opens the door to advanced biomedical applications where safety, stability and efficacy must be preserved without compromising the integrity of delicate molecules and which requires the highest quality standards. What distinguishes HTL Biotechnology’s biopolymer platforms in the market today? HTL Biotechnology has built its reputation on delivering pharmaceutical‑grade biopolymers (hyaluronic acid, polynucleotides and recombinant collagen) with unmatched purity and consistency. Since its founding in 1992, the company has focused on premium quality positioning. With more than 30 years of experience, HTL Biotechnology guarantees pharmaceutical-grade biopolymers of exceptional purity and exemplary consistency to our clients. We have had no batch recalls in 30 years, a record that underlines the rigor and reliability embedded in our processes. This was made possible by our fully-integrated site in France, where R&D laboratories, GMP manufacturing, quality control, and regulatory expertise are brought together under one roof. Such integration allows us to support our clients seamlessly throughout their product development journey, from early innovation through to global commercialization.Also, the inauguration of our new sterile hyaluronic acid production unit expands the possibilities for our HA to be used in advanced formulations with thermo-sensitive active ingredients, while upholding the uncompromising quality that defines HTL Biotechnology.Our operations are guided by internationally recognized standards, including ISO 13485 certification, which ensures the quality and safety required by medical device manufacturers worldwide.In addition, our Halal certification provides our customers with a significant advantage in accessing and expanding into markets where these requirements are essential for commercialization.Beyond certifications, our commitment to supporting global growth is reflected in the Drug Master Files we maintain across five continents, enabling our clients to accelerate product registration and bring innovative therapies to markets across the world more efficiently. By combining craftsmanship with pharmaceutical rigor, supported by state-of-the-art equipment and advanced bio-production methods, we ensure that every batch produced not only meets the strictest standards, but also delivers the reliability and consistency needed across the entire healthcare ecosystem. HIGHLIGHTS// Biopolymers with unmatched purity/record of no batch recalls/integrated facility in France/operations guided by global standards/new sterile HA unit for advanced formulations  Navigating the complex and evolving regulatory frameworks across global markets can be challenging for healthcare companies. Can you tell us more about how HTL Biotechnology supports its partners in this area? Regulatory support is part of our core premium services offer. We provide pharmaceutical regulatory support to ensure products meet the necessary compliance standards, so our partners can focus on their growth. Our dedicated regulatory professionals bring global and regional expertise, with a team specifically supporting customers in Asia. We offer personalized assistance adapted to their products and to the compliance standards of the target market. This includes personalized case-management support for regulatory file submissions with the concerned health authorities to minimize risks of refusal or delay, with the aim of achieving approval quickly and smoothly.Our offer for regulatory support continues beyond approval. We continuously monitor updates to regulations and provide post-commercialization support to our partners to help them manage any necessary regulatory updates.HIGHLIGHTS// Regulatory support offered as premium service/global and regional expertise/personalized case management for faster approvals/continuous regulatory support  How does HTL Biotechnology integrate sustainability and corporate responsibility into its operations? Sustainability is embedded in HTL Biotechnology’s strategic vision and day-to-day operations. In 2024, the company renewed its commitment to environmental responsibility by reinforcing its corporate social responsibility (CSR) roadmap. Tangible progress was made across multiple fronts: a 27 percent reduction in greenhouse gas emissions per kilogram of HA produced between 2021 and 2024, and a 34 percent reduction in water consumption per kilogram of HA since 2020. In 2024, we renewed the ISO 14001:2015 certification for its environmental management system, reflecting rigorous audit protocols and continual improvement cycles. All employees have been trained in the ISO 14001-certified environmental management system, and 78 percent of critical suppliers have signed HTL Biotechnology’s Responsible Purchasing Charter.These results reflect HTL Biotechnology’s structured and proactive approach to reducing its environmental footprint while maintaining the highest standards of quality and compliance.HIGHLIGHTS// Sustainability embedded in strategic vision/strong CSR roadmap with measurable progress/reduction in greenhouse gas emissions/responsible sourcing 

    Impressions: 2209

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/over-500-million-syringes-of-our-hyaluronic-acid-have-been-safely-used-worldwide

    PharmaCompass
    04 Nov 2025
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    ReelPharmaYour API, Our ExpertiseYour API, Our Expertise

    Your API, Our Expertise
    Your API, Our Expertise

    reelYour API, Our Expertise

    This PharmaReel showcases Minakem as a trusted partner for APIs, HPAPIs and steroids from FDA/GMP-certified sites, offering generic & custom solutions and CDMO services from lab to commercial supply, backed by regulatory know-how.

    Impressions: 514

    read-more

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

    Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

    The global pharmaceutical excipients market continued to evolve in the third quarter (Q3) of 2025, supported by rising demand for functional excipients, growth in production of generics, and advances in drug delivery technologies. The global market for pharmaceutical excipients was estimated at US$ 9.8 billion to US$ 10.7 billion in 2024, and is projected to grow at a compound annual growth rate (CAGR) of 4.1 to 6.6 percent through 2030. At this pace, the market is expected to reach US$ 13.05 billion to US$ 14.86 billion by 2030. Europe retained the largest market share in 2024, followed by Asia-Pacific. Key drivers shaping the excipients market include the rising prevalence of chronic diseases, expansion of biologics and biosimilars, and increasing quality and regulatory expectations. Increased investments in facility expansions and ongoing reforms in clinical trial regulations are also facilitating market growth. The sector remains highly competitive and fragmented. Major excipient providers include BASF, Roquette, Gangwal Healthcare, DuPont, Evonik, Seqens, SPI Pharma, PMC Isochem, Croda International, Pfanstiehl, Colorcon, Kewpie Corporation, ICE Pharma, Nanjing Well Pharmaceutical, Merck KGaA owned MilliporeSigma, Minakem, Ashland Global, Actylis and Nippon Fine Chemical.  View Our Dashboard on Major Excipient Companies in 2025 (Free Excel Available)  Evonik in partnership with Ethris; Colorcon Ventures invests in Phytolon   The market saw strategic collaborations across the excipients and drug formulation ecosystem in Q3 2025. Evonik entered into a partnership with Ethris to strengthen its nucleic acid delivery platform. The collaboration integrates Ethris’ proprietary technology — its lipidoid nanoparticle platform, known as SNaP LNP — into Evonik’s CDMO offerings, enhancing the latter’s ability to support RNA-based therapeutics from concept to clinic. Colorcon Ventures, the investment arm of Colorcon, announced a strategic investment in Israel-based Phytolon. The biotechnology start-up uses precision fermentation to develop natural colorants. The investment underscores Colorcon’s commitment to next-generation coloring technologies that support cleaner-label formulations and innovation in oral solid dosage coatings.  View Our Dashboard on Major Excipient Companies in 2025 (Free Excel Available)   Evonik launches MaxiPure Polysorbate 80; Asahi Kasei expands its portfolio The quarter saw continued innovation in high-purity and injectable-grade excipients. Evonik introduced MaxiPure Polysorbate 80, a high-purity injectable-grade surfactant designed for biologics and parenteral formulations. This excipient addresses key challenges such as protein stability, viral inactivation, and the solubilization of hydrophobic APIs, while meeting regulatory expectations across global markets. Asahi Kasei expanded its Sonanos portfolio of excipients with two new products — Sonanos PG (optimized for sustained release of biologics and peptides while supporting patient-friendly dosing)  and Sonanos DS (developed to enhance solubility of poorly water-soluble APIs). These additions reflect growing industry demand for dosage optimization, stability, and specialized delivery of complex molecules. Gangwal Healthcare operates EXCiPACT-certified GMP facilities and offers a broad range of functional excipients, including co-processed blends like ProBlend, Starlose, and Microlose. Its excipients, including Solvostar (sodium starch glycolate) and Sallyso (croscarmellose sodium), support enhanced tablet disintegration and drug release. The company also provides taste-masking agents such as SucreX (sucralose) and CutCal (neotame), supporting the development of patient-friendly oral dosage forms.  View Our Dashboard on Major Excipient Companies in 2025 (Free Excel Available)   Colorcon, Gattefossé, Croda, Roquette, Clariant expand manufacturing capacities Manufacturing investments and facility expansions remained a key trend during Q3 2025. Colorcon inaugurated a new state-of-the-art, film coating manufacturing facility in Johor, Malaysia. The site incorporates energy-efficient systems and advanced production technologies to strengthen Colorcon’s functional-excipient supply network across Asia. Gattefossé opened a new lipid-based excipient facility in Texas (US), marking a strategic expansion of its North American manufacturing footprint. Croda International expanded its Leek, UK facility with a lipid system synthesis unit and enhanced R&D capabilities. The site will support the launch of Super Refined Poloxamer 188, a highly purified fast-dissolving granular excipient. Roquette announced the opening of a dedicated innovation center in São Paulo, Brazil, strengthening its engagement with regional drug developers. Clariant expanded its Daya Bay, China facility, adding a second spray tower dedicated to pharmaceutical excipient production. The upgraded site increases capacity for excipients used in laxatives and other formulations. BASF also strengthened its commitment to biopharma and pharmaceutical ingredients with a new GMP Solution Center in Michigan (US). The facility expands BASF’s network of poloxamer (a synthetic polymer) manufacturing sites. With state-of-the-art clean room packaging and high-sensitivity analytical testing, this new facility will enable close collaboration with BASF’s customers on customized chemistries for product development.  View Our Dashboard on Major Excipient Companies in 2025 (Free Excel Available)   India mandates excipient disclosure; new rules to apply from March 2026  India has made it mandatory to disclose excipient details from March 2026 under the country’s new Drugs (2nd Amendment) Rules, 2025. This applies to Schedule H2 medicines. The final notification expands earlier draft requirements by mandating qualitative excipient details in QR codes on product packaging. This should enhance transparency and support patient safety. Meanwhile, US pharmaceutical groups have responded to the US Food and Drug Administration’s draft guidance proposing simplified pathways for replacing color additives in drug products. Industry associations have supported draft guidance, noting that it reduces regulatory burden while maintaining product quality and consistency.  View Our Dashboard on Major Excipient Companies in 2025 (Free Excel Available)   Our view While the fast-growing generics market is creating demand for cost-effective and versatile excipients, the market is also witnessing innovations tailored to the specialized needs of biologics and biosimilars. India is poised to become a key player in the global excipient market, supported by the rapid growth in its generic drug industry, expansion of its health infrastructure and increasing investments in R&D. The new excipient-disclosure rules, therefore, are likely to benefit the global excipient industry by improving transparency and strengthening quality ecosystems.
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 480

    https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-evonik-launches-high-purity-excipients-india-mandates-disclosures-from-march-2026

    #PharmaFlow by PHARMACOMPASS
    20 Nov 2025
    Share Share

    NEWS #PharmaBuzz

    [Sponsored by another company]read-more
    read-more
    GSK, Anaptysbio sue each other over Jemperli revenue
    GSK, Anaptysbio sue each other over Jemperli revenue

    22 Nov 2025

    // BIOPHARMADIVE

    https://www.biopharmadive.com/news/anaptysbio-gsk-tesaro-sue-jemperli-royalty/806168/

    BIOPHARMADIVE
    22 Nov 2025
    Share Share
    GSK Partners LTZ Therapeutics For Advanced Cancer Treatments
    GSK Partners LTZ Therapeutics For Advanced Cancer Treatments

    21 Nov 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/rd/gsk-teams-up-with-ltz-therapeutics-to-launch-next-generation-cancer-therapies-18293

    INDPHARMAPOST
    21 Nov 2025
    Share Share
    GSK Fleming Initiative Launch New Fight Against Antimicrobial
    GSK Fleming Initiative Launch New Fight Against Antimicrobial

    21 Nov 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/rd/gsk-and-fleming-initiative-launch-bold-new-fight-against-antimicrobial-resistance-18292

    INDPHARMAPOST
    21 Nov 2025
    Share Share
    GSK Pens $50M Pact To Join Big Pharma Peers In Emerging Modality
    GSK Pens $50M Pact To Join Big Pharma Peers In Emerging Modality

    19 Nov 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/gsk-pens-50m-ltz-pact-join-big-pharma-peers-emerging-modality

    FIERCE BIOTECH
    19 Nov 2025
    Share Share
    Life Sciences' Top Women of 2025
    Life Sciences' Top Women of 2025

    17 Nov 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/2025s-fiercest-women-life-sciences

    FIERCE PHARMA
    17 Nov 2025
    Share Share
    NPPA Revokes Decision Denying GSK's Antifungal Formulation
    NPPA Revokes Decision Denying GSK's Antifungal Formulation

    08 Nov 2025

    // PHARMABIZ

    https://www.pharmabiz.com/NewsDetails.aspx?aid=182304&sid=1

    PHARMABIZ
    08 Nov 2025
    Share Share
    Contact GSK and get a quotation

    GSK is a supplier offers 142 products (APIs, Excipients or Intermediates).

    Find a price of Cefuroxime Sodium bulk with DMF, CEP offered by GSK

    Find a price of Fluticasone Propionate bulk with DMF, CEP offered by GSK

    Find a price of Amoxicillin Trihydrate bulk with CEP offered by GSK

    Find a price of Betamethasone Valerate bulk with CEP offered by GSK

    Find a price of Ceftazidime bulk with CEP offered by GSK

    Find a price of Clavulanic Acid bulk with CEP offered by GSK

    Find a price of Clobetasol Propionate bulk with CEP offered by GSK

    Find a price of Salbutamol Sulphate bulk with CEP offered by GSK

    Find a price of Ceftazidime bulk with DMF offered by GSK

    Find a price of Cefuroxime Axetil bulk offered by GSK

    Find a price of Clavulanic Acid bulk offered by GSK

    Find a price of Fluticasone Furoate bulk with DMF offered by GSK

    Find a price of Fluticasone Propionate bulk with DMF offered by GSK

    Find a price of Griseofulvin bulk offered by GSK

    Find a price of Labetalol Hydrochloride bulk offered by GSK

    Find a price of Mupirocin Calcium bulk offered by GSK

    Find a price of Paroxetine Hydrochloride bulk with DMF offered by GSK

    Find a price of Salbutamol Sulphate bulk with DMF offered by GSK

    Find a price of Salmeterol Xinafoate bulk with DMF offered by GSK

    Find a price of Umeclidinium Bromide bulk with DMF offered by GSK

    Find a price of Vilanterol Trifenatate bulk with DMF offered by GSK

    Find a price of Live attenuated mumps bulk bulk with JDMF offered by GSK

    Find a price of 6-Aminopenicillanic Acid bulk offered by GSK

    Find a price of Albendazole bulk offered by GSK

    Find a price of Amoxicillin Sodium bulk offered by GSK

    Find a price of Amoxicillin Trihydrate bulk offered by GSK

    Find a price of Ampicillin bulk offered by GSK

    Find a price of Ampicillin Sodium bulk offered by GSK

    Find a price of Ampicillin Trihydrate bulk offered by GSK

    Find a price of Auranofin bulk offered by GSK

    Find a price of Beclomethasone Dipropionate bulk offered by GSK

    Find a price of Betamethasone Dipropionate bulk offered by GSK

    Find a price of Betamethasone Valerate bulk offered by GSK

    Find a price of Calcitonin bulk offered by GSK

    Find a price of Caramiphen Ethanedisulfonate bulk offered by GSK

    Find a price of Carbenicillin Indanyl bulk offered by GSK

    Find a price of Cephalexin bulk offered by GSK

    Find a price of Cephalosporin bulk offered by GSK

    Find a price of Cephradine bulk offered by GSK

    Find a price of Chlorpheniramine Maleate bulk offered by GSK

    Find a price of Cimetidine bulk offered by GSK

    Find a price of Clobetasol Propionate bulk offered by GSK

    Find a price of Clobetasone Butyrate bulk offered by GSK

    Find a price of Cloxacillin Benzathine bulk offered by GSK

    Find a price of Cloxacillin Sodium bulk offered by GSK

    Find a price of Deoxyuridine bulk offered by GSK

    Find a price of Diethylcarbamazine Citrate bulk offered by GSK

    Find a price of Diphenidol bulk offered by GSK

    Find a price of Diphenylpyraline bulk offered by GSK

    Find a price of Dopamine bulk offered by GSK

    Find a price of Doxepin Hydrochloride bulk offered by GSK

    Find a price of Fondaparinux Sodium bulk offered by GSK

    Find a price of Hydrochlorothiazide bulk offered by GSK

    Find a price of Isopropamide Iodide bulk offered by GSK

    Find a price of Liothyronine Sodium bulk offered by GSK

    Find a price of Megestrol Acetate bulk offered by GSK

    Find a price of Methicillin bulk offered by GSK

    Find a price of Mupirocin bulk offered by GSK

    Find a price of Nafcillin Sodium bulk offered by GSK

    Find a price of Oxacillin Sodium bulk offered by GSK

    Find a price of Paroxetine Hydrochloride bulk offered by GSK

    Find a price of Penicillin G Potassium bulk offered by GSK

    Find a price of Propyliodone bulk offered by GSK

    Find a price of Sodium Dicloxacillin bulk offered by GSK

    Find a price of Streptokinase bulk offered by GSK

    Find a price of Streptomycin bulk offered by GSK

    Find a price of Sucralfate bulk offered by GSK

    Find a price of Tetanus Immunoglobulin bulk offered by GSK

    Find a price of Ticarcillin bulk offered by GSK

    Find a price of Ticarcillin Monosodium bulk offered by GSK

    Find a price of Tranylcypromine Sulfate bulk offered by GSK

    Find a price of Trifluoperazine Hydrochloride bulk offered by GSK

    Find a price of Vitamin B12 bulk offered by GSK

    Find a price of Zidovudine bulk offered by GSK

    Find a price of COMPOUND 904 bulk offered by GSK

    Find a price of O/4 DIHYDROCHLORIDE DIHYRATE (CPZ ROUTE) bulk offered by GSK

    Find a price of BUILDINGS AND FACILITIES IN SEALS SANDS, ENGLAND bulk offered by GSK

    Find a price of 0/4 DIHYDROCHLORIDE DIHYDRATE (CEPHALORIDINE ROUTE-CP)-ULVERSTON PLANT bulk offered by GSK

    Find a price of G. SITE FACILITIES UTILIZED IN SPEKE LIVERPOOL (UK) bulk offered by GSK

    Find a price of FACIL, PERSONNEL AND GENERAL OPERATING PROCEDURES IN HARLOW, ESSEX. bulk offered by GSK

    Find a price of FACILITIES, METHODS AND CONTROLS bulk offered by GSK

    Find a price of FACILS AND GEN OPER PROCEDS AT THE ULVERSTON PLANT bulk offered by GSK

    Find a price of BRL 47539 (2-ACETOXYMETHYL-4-IODOBUT-1-YL-ACETATE) bulk offered by GSK

    Find a price of SYNTHESIS & QUALITY CONTROLS FOR 5,7-DICHLORO-8-HYDROXYQUINOLONE bulk offered by GSK

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN CAROLINA, PUERTO RICO. bulk offered by GSK

    Find a price of GENERAL OPERATING PROCEDURES FOR THE HEPPIGIES, BELGIUM--ANTIBIOTICS bulk offered by GSK

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN CIDRA, PUERTO RICO. bulk offered by GSK

    Find a price of CHIMERIC (MACAQUE VARIABLE/HUMAN CONSTANT) (RECOMBINANT, CHO CELLS) MONOCLONAL ANTIBODY (SB 210396; CE9.1) TO HUMAN CD4 ANTIGEN bulk offered by GSK

    Find a price of HIV VACCINE (GPL 120/NEFTA/ASO2A) bulk offered by GSK

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN GREENVILLE, NORTH CAROLINA. bulk offered by GSK

    Find a price of MANUFACTURING SITE, FACILITIES, PESONNEL, AND GENERAL OPERATING PROCEDURES IN WEST SUSSEX, ENGLAND. bulk offered by GSK

    Find a price of FACILITIES AND OPERATING PROCEDURES IN TIANJIN, CHINA bulk offered by GSK

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL AND GENERAL OPERATING PROCEDURES IN SINGAPORE bulk offered by GSK

    Find a price of G. FACILITIES LOCATED IN JURONG, SINGAPORE bulk offered by GSK

    Find a price of PENN CHEMICALS PRODUCTION FACILITY IN COUNTY CORK, IRELAND bulk offered by GSK

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN MONTROSE, ANGEES, SCOTLAND. bulk offered by GSK

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN CUERNAVACA, MEXICO. bulk offered by GSK

    Find a price of FACILITIES&CONTROLS AT HARLOW AND GREAT BURGH RESEARCH SITES, ENGLAND bulk offered by GSK

    Find a price of FACIL, PERSONNEL & GENL OPER PROCED IN GREAT BURGH, EPSOM, U.K. bulk offered by GSK

    Find a price of ENTRENOL bulk offered by GSK

    Find a price of FACILITIES & CONTROLS OF THE WELLCOME FOUNDATION IN KENT ENGLAND bulk offered by GSK

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN TONBRIDGE, KENT, ENGLAND. bulk offered by GSK

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES. bulk offered by GSK

    Find a price of GR, CONTROL PROCEDURES & FACILITIES-MYERSTOWN, PA., PLANT bulk offered by GSK

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN BOMBAY, INDIA. bulk offered by GSK

    Find a price of FACILITY IN BUCKHAVEN, UNITED KINGDOM bulk offered by GSK

    Find a price of MANUFACTURING SITE AND FACILITIES FOR ANNAN, UK PLANT bulk offered by GSK

    Find a price of FACILITIES UTILIZED IN WARE HERTS, UNITED KINGDOM bulk offered by GSK

    Find a price of FACILITY LOCATED IN EDINBURG, SCOTLAND bulk offered by GSK

    Find a price of 7-ACA TOSYLATE bulk offered by GSK

    Find a price of MANUFACTURING FACILITY AT VERONA, ITALY. bulk offered by GSK

    Find a price of FACILITIES AND MANUFACTURING bulk offered by GSK

    Find a price of 'ZENTEL' 'TILTAB' TABLETS bulk offered by GSK

    Find a price of GENERAL OPERATING PROCEDURES SINGAPORE PLANT bulk offered by GSK

    Find a price of MANUFACTURING PRODUCTION FACILITY IN TORONTO, CANADA bulk offered by GSK

    Find a price of CLENOLIXIMAB [CHIMERIC (MACAQUE/HUMAN) MONOCLONAL ANTIBODY (SB-217969) (CHO CELLS, SMITHKLINE BEECHAM) TO CD4] bulk offered by GSK

    Find a price of L-DM1 bulk offered by GSK

    Find a price of ASO1B ADJUVANT SYSTEM bulk offered by GSK

    Find a price of Abacavir Sulfate bulk offered by GSK

    Find a price of Benzyl Penicillin bulk offered by GSK

    Find a price of Cabotegravir bulk offered by GSK

    Find a price of Cabotegravir Sodium bulk offered by GSK

    Find a price of CAS 103639-04-9 bulk offered by GSK

    Find a price of Daprodustat bulk offered by GSK

    Find a price of Dolutegravir Sodium bulk offered by GSK

    Find a price of Dutasteride bulk offered by GSK

    Find a price of Epsiprantel bulk offered by GSK

    Find a price of Fluticasone Furoate bulk offered by GSK

    Find a price of Lacidipine bulk offered by GSK

    Find a price of Lamivudine bulk offered by GSK

    Find a price of Nabumetone bulk offered by GSK

    Find a price of Naratriptan Hydrochloride bulk offered by GSK

    Find a price of Nelarabine bulk offered by GSK

    Find a price of Ondansetron bulk offered by GSK

    Find a price of Pazopanib Hydrochloride bulk offered by GSK

    Find a price of Ranitidine Hydrochloride bulk offered by GSK

    Find a price of Retapamulin bulk offered by GSK

    Find a price of Trametinib bulk offered by GSK

    Find a price of Umeclidinium Bromide bulk offered by GSK

    Find a price of Vilanterol Trifenatate bulk offered by GSK

    Find a price of Zanamivir bulk offered by GSK

    Find a price of MEDICATED FEED bulk offered by GSK